Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11976101 Multi-level specific targeting of cancer cells
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
September 2, 2021
0
Date of Patent
May 7, 2024
0
Patent Application Number
17465145
0
Patent Citations
US Patent 7332586 Nanoparticle delivery vehicle
0
US Patent 7498177 Quantum dots and their uses
0
US Patent 7517964 RS7 antibodies
0
US Patent 7531624 Nuclear targeting sequence
0
US Patent 7585636 Protein subcellular localization assays using split fluorescent proteins
0
US Patent 7550650 Production of a transgenic avian by cytoplasmic injection
0
US Patent 8362207 Multi-level specific targeting of cancer cells with IL-13
0
US Patent 6884603 Nucleic acids encoding IL13 mutants
0
US Patent 6949245 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
0
Patent Inventor Names
Waldemar Debinski
0
Hetal Pandya
0
Denise Gibo
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11976101
0
Patent Primary Examiner
Prema M Mertz
0
CPC Code
C07K 14/5437
0
Find more entities like US Patent 11976101 Multi-level specific targeting of cancer cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE